New algorithm available for C. difficile testing

Effective Monday, Sept. 9​, Norton Healthcare replaced the algorithm for C. difficile testing with a new approach designed to provide clinicians greater clarity regar​ding the significance of a positive result.

The new algorithm will begin with a PCR test, which will determine if C. difficile organism is present.

​If that is positive, a second test will be performed to detect free toxin. The presence of free toxin has been shown to be correlated most closely with true C. difficile infection as opposed to asymptomatic colonization with C. difficile. ​​


Get Our Monthly Newsletter

Stay informed on the latest offerings and treatments available at Norton Healthcare by subscribing to our monthly enewsletter.

Subscribe

Make a Referral

Partnering with you in caring for your patients.

Refer a Patient
Are You a Patient?
Provider Spotlight

Mia Jusufbegovic, M.D.

Mia Jusufbegovic, M.D., has joined Norton Cancer Institute as its first head and neck oncology and microvascular reconstructive surgeon treating complex ear, nose and throat oncology cases.

Read More

Search our entire site.